UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Holdings in Humana Inc. $HUM

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Humana Inc. (NYSE:HUM) by 16.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,136,538 shares of the insurance provider’s stock after purchasing an additional 158,528 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned 0.94% of Humana worth $300,728,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Woodline Partners LP lifted its holdings in Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares in the last quarter. Empowered Funds LLC lifted its holdings in Humana by 814.8% in the 1st quarter. Empowered Funds LLC now owns 35,093 shares of the insurance provider’s stock worth $9,286,000 after purchasing an additional 31,257 shares in the last quarter. MBB Public Markets I LLC purchased a new position in Humana in the 1st quarter worth approximately $315,000. United Services Automobile Association purchased a new position in Humana in the 1st quarter worth approximately $756,000. Finally, Caxton Associates LLP purchased a new position in Humana in the 1st quarter worth approximately $417,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on HUM. Barclays boosted their price target on Humana from $275.00 to $315.00 and gave the stock an “equal weight” rating in a report on Friday, September 5th. Truist Financial reduced their price objective on Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Wells Fargo & Company reduced their price objective on Humana from $348.00 to $344.00 and set an “overweight” rating on the stock in a research note on Thursday, August 14th. Morgan Stanley reduced their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Finally, Wall Street Zen downgraded Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Seven analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $289.24.

Humana Stock Performance

NYSE HUM opened at $273.35 on Thursday. The company has a market cap of $32.88 billion, a P/E ratio of 20.98, a P/E/G ratio of 1.60 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The business’s 50 day moving average price is $263.78 and its 200-day moving average price is $256.90. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $333.79.

Humana (NYSE:HUM) last released its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s payout ratio is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.